Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0035
0.00 (0.00%)
Jan 7, 2026, 2:23 PM EST
Pharmagreen Biotech Market Cap
Pharmagreen Biotech has a market cap or net worth of $2.32 million as of January 7, 2026. Its market cap has increased by 118.75% in one year.
Market Cap
2.32M
Enterprise Value
2.63M
Revenue
3.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 5, 2018, Pharmagreen Biotech's market cap has decreased from 57.68M to 2.32M, a decrease of -95.97%. That is a compound annual growth rate of -34.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 2.32M | 59.09% |
| Dec 31, 2025 | 1.46M | 46.67% |
| Dec 31, 2024 | 995.47K | 150.00% |
| Dec 29, 2023 | 398.19K | -71.75% |
| Dec 30, 2022 | 1.41M | -81.11% |
| Dec 31, 2021 | 7.46M | 186.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |